Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases
Combining biologics and/or small molecules may be effective for IBD patients who fail to achieve remission with monotherapy; however, safety profiles need to be carefully considered prior to implementing these strategies in clinical practice.
Authors
- Parakkal Deepak (ORCID: https://orcid.org/0000-0002-3436-9784)
- Suzannah Bergstein (ORCID: https://orcid.org/0000-0003-4917-1268)
- Bruce E. Sands (ORCID: https://orcid.org/0000-0001-5762-5042)
- Andrés Yarur (ORCID: https://orcid.org/0000-0003-2293-5555)
- Deborah A. Thomas (ORCID: https://orcid.org/0000-0002-2656-343X)
- Quazim A. Alayo (ORCID: https://orcid.org/0000-0001-5524-7105)
- Jean‐François Rahier (ORCID: https://orcid.org/0000-0002-7738-0238)
- Ali Osman (ORCID: https://orcid.org/0000-0003-0226-8230)
- Elizabeth A. Spencer (ORCID: https://orcid.org/0000-0002-6787-1164)
- Scott R. Anderson (ORCID: https://orcid.org/0000-0003-2286-2704)
- Mohammad Ali Zamani (ORCID: https://orcid.org/0000-0001-5350-645X)
- Jean–Frédéric Colombel
Institutions
- Cedars-Sinai Medical Center (US)
- Washington University in St. Louis (US)
- CHU Dinant Godinne UCL Namur (BE)
- Institut de Recherche en Santé Digestive (FR)
- Tehran University of Medical Sciences (IR)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-07-25
- DOI
- https://doi.org/10.1093/ibd/izaf188
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82